PSTV
PSTV
NASDAQ · Biotechnology

Plus Therapeutics Inc

$0.16
-0.01 (-4.18%)
As of Apr 1, 10:10 PM ET ·
Financial Highlights (FY 2026)
Revenue
156.93M
Net Income
-349,674,517
Gross Margin
64.4%
Profit Margin
-222.8%
Rev Growth
D/E Ratio
0.84
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 64.4% 60.8% 60.8% 60.8%
Operating Margin -252.3% 3.3% 3.3% 3.5%
Profit Margin -222.8% 2.3% 3.0% 3.0%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 156.93M 35.79M 31.57M 32.41M
Gross Profit 101.00M 21.76M 19.20M 19.71M
Operating Income -395,960,000 1.17M 1.04M 1.13M
Net Income -349,674,517 827.5K 932.2K 975.1K
Gross Margin 64.4% 60.8% 60.8% 60.8%
Operating Margin -252.3% 3.3% 3.3% 3.5%
Profit Margin -222.8% 2.3% 3.0% 3.0%
Rev Growth +6.8% +6.0% -3.2%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 9.49M 13.26M 17.01M 14.45M
Total Equity 11.35M 21.76M 23.46M 24.58M
D/E Ratio 0.84 0.61 0.73 0.59
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -237,225,462 1.82M 1.58M 1.77M
Free Cash Flow 629.7K 483.5K 562.4K